|Articles|May 2, 2015
Jasmine Martin Discusses Oral Adherence
Author(s)Jasmine Martin
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
Advertisement
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
“If patients aren’t taking their drugs, then how do we know that the outcomes will be [the same as] what the clinical trial [outcomes] were?” Martin asks.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
KTX-1001 Elicits Responses in Some With Multiple Myeloma
3
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
4
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
5